En
It
De
日本語
中文
Es
Abstract
On-Body Delivery Systems (OBDS) are gaining traction as a novel solution for administering complex drug formulations, especially for high-volume and high-viscosity biologics. As adoption increases, the industry faces two key challenges: ensuring ease of use and addressing the environmental impact of single-use devices. Can OBDS effectively balance usability and sustainability without compromises?
Building on this question, this webinar will explore how semi-reusable and pre-loaded OBDS designs, such as Stevanato Group’s Vertiva® platform, can help address these challenges. Drawing on insights from multiple and life cycle assessments, we will highlight key factors in developing OBDS that minimize environmental impact while ensuring ease of use for patients.
Addressed Challenges
Learning Objectives
Vice President of Sales and Business Development, Drug Delivery Systems
Mr. O’Hagan joined the Stevanato Group as Vice President of Business Development of Drug Delivery Systems in January 2025. Prior to joining the Stevanato Group, he was General Manager of Haselmeier, the US entity of the Haselmeier Group based in Stuttgart, Germany (now a medmix company). Joining the company in November of 2013, Mr. O’Hagan established the US entity and grew the America region. Mr. O’Hagan has spent the last 21 years focused on the development and manufacturing of medical devices. He previously worked at Radius Product Development (now a Jabil Company) as the Global director of Business Development from 2003 to 2010, and as Sr. Director of Business Development at Flextronics Medical from 2010 to 2013. Mr. O’Hagan earned a Bachelor of Science in Plastics Engineering from the University of Lowell and a Master of Business Administration from Worcester Polytechnic Institute.
Core Team Leader, On-Body Delivery Systems
Pierre Ducarouge is Core Team Leader at Stevanato Group, where he has been leading the development of the company’s On-Body Delivery System platform since 2021. With over a decade of experience in the medical device industry, he brings expertise in project management, R&D leadership, and cross-functional team coordination. Before joining Stevanato Group, Pierre spent seven years at Becton Dickinson, where he held roles in R&D and project management focused on drug delivery devices and primary containers. During this time, he gained comprehensive expertise across the full product development lifecycle in an international setting. Pierre holds a Master’s Degree in Mechanical and Polymer Engineering from INSA de Lyon (France), providing a solid technical foundation that complements his project management skills and industry experience.
Human Factors Engineer
Carlo Valbonesi leads the Human Factors workstream for Stevanato Group’s On-Body Delivery Platform, since joining in 2023. Previously, he led Human Factors activities at Janssen (now Johnson & Johnson Innovative Medicine) on various drug-only and combination products. Since 2006, Carlo has consulted in Human Factors and usability across consumer and safety-critical industries, including digital services, telecom, manufacturing, aviation, and railway transportation. He holds a Master’s Degree in Communication Studies, with a focus on Human-Machine Interaction, from the University of Siena.